Autoplaque vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Autoplaque

by APQ Health (formerly Cedars-Sinai Medical Center: AIM)

FEops HEARTguide

by FEops

AI Verdict

Autoplaque specializes in the quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, primarily for heart attack risk prediction and treatment guidance. In contrast, FEops HEARTguide focuses on pre-operative planning for structural heart procedures, using predictive simulations and digital twin technology to optimize device sizing and positioning. While both are cardiology AI tools leveraging CT imaging, their distinct applications in coronary disease diagnosis versus structural heart intervention planning make them adjacent rather than direct competitors.

Choose Autoplaque if…

Choose Autoplaque if your primary need is detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians focused on accurately assessing a patient's heart attack risk and guiding medical treatment based on the precise characterization of atherosclerotic disease. Its workstation-based deployment allows for in-depth post-processing and review of coronary anatomy.

View Autoplaque →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you require advanced predictive simulations and digital twin technology for planning complex structural heart procedures. This cloud-based platform is best suited for optimizing device sizing and positioning pre-operatively, enabling clinicians to evaluate potential outcomes and personalize interventions for improved patient results. It excels in scenarios where precise anatomical measurements and simulated device interactions are critical for procedural success.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Autoplaque	FEops HEARTguide
Deployment	Workstation-based post-processing application, runs on Windows or Mac OS.	Cloud Based platform
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

FEops HEARTguide

FEops HEARTguide (Tool B) offers superior usability due to its cloud-based platform, providing 'anytime, anywhere access' and fostering 'improved collaboration' among users. In contrast, Autoplaque (Tool A) is workstation-based, which may limit its accessibility and integration within diverse clinical environments. FEops HEARTguide is also explicitly described as intuitive and easy to use for clinicians.

Clinical Value

FEops HEARTguide

Both tools are FDA-cleared and offer significant clinical value in cardiology. However, FEops HEARTguide (Tool B) provides predictive simulations and digital twin technology for optimizing device sizing and positioning in structural heart procedures, directly impacting interventional outcomes and procedural efficiency. This proactive, interventional planning, supported by multiple clinical studies demonstrating improved efficiency and outcomes, gives it a slight edge over Autoplaque's diagnostic and risk prediction focus.

Pricing & Value

Tie

Both Autoplaque (Tool A) and FEops HEARTguide (Tool B) have undisclosed pricing, requiring direct contact for information. Without any transparent pricing details or a general pricing model, it is impossible to conduct a meaningful comparison of their value propositions. Therefore, a definitive winner cannot be determined in this dimension.

Enterprise Readiness

FEops HEARTguide

FEops HEARTguide (Tool B) demonstrates stronger enterprise readiness with its cloud-based deployment, explicit HIPAA compliance, and features like multi-factor authentication and secure external collaboration. Autoplaque (Tool A) is workstation-based and lacks specified HIPAA compliance or BAA information, making it less clear regarding its suitability for large-scale enterprise integration.

Innovation

FEops HEARTguide

FEops HEARTguide (Tool B) exhibits greater innovation through its 'digital twin technology' and 'predictive simulation' for patient-specific procedural planning. This approach moves beyond traditional diagnostics to proactive, personalized interventional guidance. While Autoplaque (Tool A) utilizes advanced AI for plaque analysis, FEops HEARTguide's application in simulating device-anatomy interaction is a more disruptive and forward-thinking use of AI in healthcare.

Support & Docs

FEops HEARTguide

FEops HEARTguide (Tool B) has a slight advantage as it explicitly mentions a dedicated support email ([email protected]) and the availability of 'training slide decks on the platform'. Autoplaque (Tool A) only implicitly refers to a user manual in its FDA documentation, without providing details on accessible support channels or comprehensive documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Autoplaque	FEops HEARTguide
Tool Name	Autoplaque	FEops HEARTguide
Company	Cedars-Sinai Medical Center: AIM	FEops NV
Core Functionality	Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images	Structural heart procedure planning, providing predictive simulations and anatomical measurements
Key Technology	AI-powered quantitative analysis	AI and digital twin platform for predictive simulations
Input Data	CT Angiographic images	CT scan upload (DICOM interface)
Primary Benefit/Output	Aiding in heart attack risk prediction and treatment guidance	Optimize device sizing and positioning for improved patient outcomes

Videos

Demos, reviews, and walkthroughs featuring Autoplaque and FEops HEARTguide.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications for Autoplaque and FEops HEARTguide?

Autoplaque is an AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. FEops HEARTguide is a cloud-based AI and digital twin platform designed for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning.

What specific types of patient data or imaging do these tools analyze?

Autoplaque analyzes coronary plaques and luminal stenoses from CT angiography images. FEops HEARTguide analyzes cardiac computed tomography (CT) scans to create patient-specific digital twins for structural heart planning.

How do the AI capabilities of Autoplaque and FEops HEARTguide differ in their approach?

Autoplaque uses AI for quantitative analysis, detection, and characterization of coronary artery plaque, along with automated vessel, plaque, and lumen segmentation. FEops HEARTguide leverages AI for anatomical measurements and predictive simulation technology to optimize device sizing and positioning in structural heart procedures.

Which tool is more focused on diagnostic assessment versus pre-operative planning?

Autoplaque is primarily geared towards non-invasive diagnostic assessment and risk prediction related to coronary artery disease by analyzing plaque and stenosis. FEops HEARTguide is specifically designed for pre-operative planning in structural heart procedures, focusing on optimizing device selection and placement through predictive simulations.

Can clinicians interact with and modify the automated analyses provided by these tools?

Autoplaque allows for automated vessel, plaque, and lumen segmentation that is reviewable and editable by the clinician. FEops HEARTguide features semi-automatic identification and measurement of anatomical landmarks, and also offers options for manual measurements, implying clinician interaction and control.

What specific anatomical measurements or analyses can each tool provide?

Autoplaque provides biometric information including calcified plaque volume, non-calcified plaque volume, stenosis percentage, remodeling index, plaque length, and vessel diameter and area. FEops HEARTguide offers AI-based anatomical measurements and predictive simulations for evaluating device sizing, positioning, apposition, and frame deformation pre-operatively.